Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Sezary Syndrome 2Mycosis Fungoides 2Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Lymphoma, T-Cell, Cutaneous 1Lymphoma 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia 1Anemia, Refractory, with Excess of Blasts 1Anemia, Refractory 1

Interventions

Whole-Body Irradiation 2Thioguanine 2Peripheral Blood Stem Cell Transplantation 2Mycophenolic Acid 2Methotrexate 2Daunorubicin 2Cytarabine 2Asparaginase 2ruxolitinib 1merphos 1hydrocortisone hemisuccinate 1fludarabine phosphate 1fludarabine 1asparaginase erwinia chrysanthemi recombinant 1Watchful Waiting 1Tacrolimus 1Stem Cell Transplantation 1Radiotherapy 1Photopheresis 1Pentostatin 1Patient Reported Outcome Measures 1Moxifloxacin 1Morphine 1Mitoxantrone 1Methoxsalen 1Mesna 1Melphalan 1Leyk 1In Situ Hybridization, Fluorescence 1Hydrocortisone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Myeloproliferative Disorders × Methoxsalen × Clear all
NCT00045305 2023-06-28

Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes

Eastern Cooperative Oncology Group

Phase 2 Completed
17 enrolled 10 charts
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡